recent
outbreak
influenza
china
high
concern
public
health
hemagglutinin
ha
play
critic
role
influenza
entri
thu
ha
present
attract
target
antivir
previou
studi
suggest
small
molecul
tertbutyl
hydroquinon
tbhq
inhibit
entri
influenza
ha
bind
stem
loop
ha
stabil
neutral
ph
conform
ha
therebi
disrupt
membran
fusion
step
base
amino
acid
sequenc
structur
immunogen
relat
group
ha
work
show
use
pseudoviru
entri
assay
tbhq
inhibit
hamedi
entri
well
hamedi
entri
mm
use
nmr
show
tbhq
bind
stem
loop
region
std
nmr
experi
indic
aromat
ring
tbhq
make
extens
contact
ha
surfac
limit
proteolysi
experi
indic
tbhq
inhibit
influenza
entri
stabil
ha
neutral
ph
conform
togeth
work
suggest
stem
loop
region
ha
attract
target
therapeut
intervent
tbhq
wide
use
food
preserv
promis
lead
compound
membran
glycoprotein
hemagglutinin
ha
neuraminidas
na
play
critic
role
influenza
infect
antigen
properti
use
classifi
ha
na
influenza
strain
subtyp
ha
na
strain
pose
enorm
threat
human
health
exampl
pandem
influenza
outbreak
result
million
death
worldwid
fatal
rate
despit
improv
vaccin
effort
better
treatment
season
influenza
still
respons
greater
death
per
year
worldwid
high
concern
recent
outbreak
influenza
china
exhibit
mortal
rate
current
treatment
influenza
includ
tamiflu
oseltamivir
relenza
zanamivir
target
na
symmetrel
amantadin
flumadin
rimantidin
target
channel
unfortun
resist
increas
circul
influenza
strain
exampl
strain
exhibit
resist
tamiflu
moreov
recent
strain
contain
sequenc
render
insensit
channel
blocker
strain
also
show
resist
tamiflu
relenza
consequ
novel
antivir
treatment
new
target
highli
desir
ha
well
analog
envelop
protein
ebola
hiv
sarscov
mediat
viru
entri
receptor
bind
conform
chang
result
fusion
viral
target
cell
membran
base
sequenc
structur
immunogen
ha
fall
phylogenet
group
exampl
group
ha
exampl
group
ha
case
ha
synthes
precursor
subsequ
cleav
form
noncoval
complex
consist
receptor
bind
subunit
subunit
mediat
membran
fusion
entri
process
ha
undergo
seri
bind
phinduc
conform
chang
result
bind
viru
plasma
membran
entri
viru
endosom
exposur
ha
fusion
peptid
fusion
fusion
viral
endosom
membran
final
releas
viral
rna
cytoplasm
critic
natur
ha
function
make
attract
target
therapeut
small
molecul
protein
antibodi
design
inhibit
entri
either
bind
fusion
step
ie
bind
fusion
inhibitor
case
fusion
inhibitor
thought
often
bind
stem
loop
region
act
stabil
prefus
neutral
ph
conform
ha
exampl
small
aromat
molecul
tertbutyl
hydroquinon
tbhq
inhibit
hamedi
influenza
entri
bind
stem
loop
ha
tbhq
wide
use
antioxid
food
preserv
approv
concentr
mm
interestingli
fusion
inhibitor
includ
tbhq
appear
act
group
specif
manner
ie
inhibitor
group
ha
inhibit
group
ha
work
compar
inhibitori
bind
properti
tbhq
ha
ha
togeth
work
suggest
stem
loop
region
ha
attract
target
therapeut
intervent
tbhq
promis
lead
compound
inhibitori
properti
tbhq
test
pseudoviru
entri
assay
previous
describ
group
briefli
plasmid
bear
ha
strain
respect
pna
bear
influenza
neuraminidas
cotransfect
pei
polysci
inc
warrington
pa
cell
maintain
dulbecco
medium
fb
penicillinstreptomycin
fortyeight
hour
posttransfect
medium
harvest
filter
micron
filter
make
viru
stock
assay
viral
entri
cell
maintain
dulbecco
medium
fb
supplement
penicillinstreptomycin
seed
cellswel
well
cell
cultur
plate
volum
ml
follow
day
ml
viru
stock
ad
well
cell
remov
medium
experi
tbhq
pseudovirion
premix
appropri
amount
tbhq
dmso
stock
solut
dilut
plate
incub
co
incub
approxim
hour
viru
aspir
replac
medium
cell
allow
rest
anoth
hour
luciferas
activ
measur
use
luciferas
assay
system
promega
madison
wi
berthold
luminomet
run
siriu
softwar
experi
run
triplic
transfect
assay
luciferas
activ
thu
uncertainti
repres
stage
experi
case
viral
entri
level
fell
within
linear
rang
detect
ie
valu
wildtyp
mutant
never
exceed
rel
light
unit
cytotox
determin
use
celltiterglo
kit
promega
nmr
experi
perform
bruker
mhz
avanc
spectromet
equip
cryogen
tripl
reson
probe
experiment
condit
mm
ha
mm
tbhq
mm
po
ph
mm
nacl
h
h
waterlogsi
h
std
mm
nmr
tube
waterlogsi
experi
perform
previous
describ
water
select
satur
use
msec
squar
shape
puls
mix
time
sec
relax
delay
sec
std
experi
perform
previous
describ
experi
protein
h
satur
train
msec
gaussianshap
puls
hz
power
sec
reson
satur
ppm
reson
satur
ppm
relax
delay
sec
satur
puls
spectra
process
nmrpipe
hz
line
broaden
function
analyz
nmrdraw
competit
waterlogsi
experi
perform
ratio
monoclon
antibodi
ha
spectra
presenc
antibodi
correct
bind
tbhq
rel
std
defin
x
std
ob
std
max
std
dii
di
intens
observ
variou
reson
presatur
ha
error
waterlogsi
std
estim
dii
ref
n
di
di
n
ioff
ref
ndi
n
iref
nois
calcul
nmrdraw
appropri
spectrum
antibodi
waterlogsi
std
limit
proteolysi
experi
mm
ha
preincub
presenc
mm
tbhq
min
control
experi
perform
dmso
phosphatecitr
buffer
stock
solut
appropri
ph
ad
result
final
buffer
tbhq
concentr
mm
mm
respect
buffer
solut
incub
min
next
solut
neutral
ph
incub
mg
trypsin
min
proteolysi
stop
ad
ml
sd
run
buffer
heat
sampl
min
sd
page
coomassi
stain
ha
band
quantifi
use
biorad
imag
lab
subsequ
ha
band
intens
fit
nativ
ob
h
mp
n
ob
observ
intens
particular
ph
h
mp
midpoint
h
concentr
n
hill
coeffici
use
kaleidagraph
tbhq
inhibit
entri
ha
previous
group
shown
pseudoviru
contain
envelop
protein
ebola
hiv
influenza
sarscov
background
hiv
core
protein
use
surrog
infecti
viru
note
small
molecul
tbhq
report
inhibit
hamedi
influenza
entri
group
ha
phylogenet
relat
ha
accordingli
first
test
inhibitori
properti
tbhq
use
pseudovirion
contain
ha
shown
figur
tbhq
inhibit
hamedi
entri
mm
purpl
triangl
agreement
previous
report
inhibit
influenza
infect
next
test
inhibitori
properti
tbhq
use
pseudovirion
contain
ha
shown
figur
tbhq
inhibit
hamedi
entri
mm
black
squar
next
step
specif
ha
shown
lack
detect
inhibit
vsvgmediat
entri
pseudovirion
contain
unrel
envelop
protein
figur
red
circl
final
toxic
tbhq
determin
mm
shown
figur
blue
triangl
taken
togeth
experi
show
small
molecul
tbhq
inhibit
hamedi
entri
similar
potenc
influenza
infect
waterlogsi
nmr
previous
shown
use
detect
small
molecul
interact
larg
protein
complex
includ
kda
trimer
influenza
ha
accordingli
first
test
whether
tbhq
bind
recombin
ha
use
waterlogsi
experi
shown
figur
presenc
posit
phase
tbhq
reson
nmr
experi
clearli
indic
tbhq
bind
ha
previous
tbhq
shown
bind
stem
loop
ha
xray
crystallographi
moreov
monoclon
antibodi
report
bind
stem
loop
ha
consequ
test
tbhq
bind
ha
stem
loop
use
waterlogsybas
competit
assay
presenc
antibodi
shown
figur
addit
monoclon
antibodi
significantli
decreas
observ
bind
tbhq
averag
reduct
tbhq
reson
intens
suggest
antibodi
displac
compound
next
character
bind
tbhq
ha
shown
figur
tbhq
bind
ha
base
competit
nmr
experi
presenc
antibodi
tbhq
bind
stem
loop
region
ha
averag
reduct
tbhq
reson
intens
character
tbhq
interact
ha
use
std
nmr
experi
give
insight
small
molecul
h
closest
contact
protein
surfac
summari
rel
intens
tbhq
std
spectrum
shown
figur
ha
respect
base
analysi
tbhq
contact
ha
surfac
similar
aromat
h
closest
contact
interestingli
case
tertbutyl
methyl
h
exhibit
significantli
less
std
intens
suggest
distant
protein
surfac
thu
may
present
attract
site
modif
design
increas
affin
taken
togeth
nmr
experi
indic
tbhq
bind
stem
loop
ha
similar
mode
bind
influenza
entri
low
ph
endosom
trigger
larg
irrevers
conform
chang
ha
necessari
membran
fusion
previous
tbhq
shown
inhibit
hamedi
entri
stabil
ha
neutral
ph
conform
use
limit
proteolysi
assay
low
ph
conform
sensit
proteolysi
accordingli
use
limit
proteolysi
assay
test
stabil
ha
differ
ph
presenc
absenc
tbhq
shown
figur
ha
becom
suscept
proteolysi
midpoint
correspond
ph
fill
circl
solid
line
similar
previous
describ
cellcel
fusion
assay
ha
interestingli
addit
tbhq
appear
stabil
ha
proteolysi
shift
midpoint
ph
open
squar
dot
line
note
similar
size
shift
lower
ph
observ
unrel
fusion
inhibitor
ha
influenza
use
cellbas
assay
summari
limit
proteolysi
assay
suggest
tbhq
inhibit
hamedi
entri
stabil
neutral
ph
conform
therebi
disallow
conform
chang
necessari
membran
fusion
work
show
first
time
tbhq
inhibit
hamedi
entri
similar
manner
previous
character
ha
moreov
studi
suggest
tbhq
bind
stem
loop
ha
act
stabil
neutral
ph
conform
therebi
delay
conform
chang
necessari
fusion
viru
endosom
membran
taken
togeth
suggest
tbhq
attract
lead
compound
develop
antivir
direct
ha
notabl
sequenc
ident
ha
strain
use
present
studi
respons
new
outbreak
china
sequenc
ident
stem
loop
region
nonetheless
tbhq
exhibit
rel
modest
potenc
thu
suitabl
therapeut
agent
without
develop
howev
note
std
nmr
experi
suggest
site
modif
tbhq
hand
tbhq
wide
use
food
preserv
thu
may
present
potenti
addit
anim
feed
includ
bird
transmiss
agent
influenza
antivir
agent
present
small
molecul
fdaapprov
therapeut
target
ha
consequ
ha
entri
inhibitor
includ
ha
present
uniqu
opportun
treat
influenza
particularli
drugresist
influenza
strain
resist
therapeut
target
na
andor
channel
ha
